We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Pfizer | LSE:PFZ | London | Ordinary Share | COM STK USD0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.78 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMPFZ TIDMIRSH
RNS Number : 5045G
FIL Limited
20 November 2015
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION Name of person dealing (Note FMR LLC and/or one or more of its direct 1) or indirect subsidiaries And FIL Limited and/or one or more of its direct and indirect subsidiaries Company dealt in ALLERGAN PLC ---------------------------------------------- Class of relevant security Ordinary Shares and preferred convertible to which the dealings being stock disclosed relate (Note 2) ---------------------------------------------- Date of dealing 19-November-15 ---------------------------------------------- 2. INTERESTS AND SHORT POSITIONS (a) Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 3)
Ordinary Shares Long Short Number (%) Number (%) ----------------- ----------- (1) Relevant securities 15,903,452 4.03% ----------------- ----------- (2) Derivatives (other than options) ----------------- ----------- (3) Options and agreements to purchase/sell ----------------- ----------- Total 15,903,452 4.03% ----------------- -----------
The above position includes a transfer out of 8 shares.
Preferred Convertible Stock Long Short Number (%) Number (%) -------------- ----------- (1) Relevant securities 258,334 5.01% -------------- ----------- (2) Derivatives (other than options) -------------- ----------- (3) Options and agreements to purchase/sell -------------- ----------- Total 258,334 5.01% -------------- ----------- (b) Interests and short positions in relevant securities of the company, other than the
class dealt in (Note 3)
Class of relevant security: Long Short Number (%) Number (%) ----------- ----------- (1) Relevant securities ----------- ----------- (2) Derivatives (other than options) ----------- ----------- (3) Options and agreements to purchase/sell ----------- ----------- Total ----------- ----------- 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit Buy (preferred convertible stock 2.8345 conversion factor) 4,500 1,019.256 USD/ Share --------------------- --------------------- Buy 1 302.5 USD/ Share --------------------- --------------------- Buy 1,674 302.6498 USD/ Share --------------------- --------------------- Buy 2,276 302.8108 USD/ Share --------------------- --------------------- Buy 150 302.6467 USD/ Share --------------------- --------------------- Buy 5,900 302.93 USD/ Share --------------------- --------------------- Buy 3,800 306.7404 USD/ Share --------------------- --------------------- Buy 500 306.472 USD/ Share --------------------- --------------------- Buy 1,200 308.075 USD/ Share --------------------- --------------------- Buy 800 306.31 USD/ Share --------------------- --------------------- Buy 625 306.06 USD/ Share --------------------- --------------------- Buy 478 307.82 USD/ Share --------------------- --------------------- Buy 45 304.83 USD/ Share --------------------- --------------------- Buy 30 306.67 USD/ Share --------------------- --------------------- Buy 62 306.055 USD/ Share --------------------- --------------------- Buy 20 309.70 USD/ Share --------------------- --------------------- Buy 9 306.86 USD/ Share --------------------- --------------------- Buy 21 310.78 USD/ Share --------------------- --------------------- Sale 22 304.93 USD/ Share --------------------- --------------------- Sale 23 307.72 USD/ Share --------------------- --------------------- Sale 6 304.888 USD/ Share --------------------- --------------------- Sale 2 304.925 USD/ Share --------------------- --------------------- Sale 3 304.88 USD/ Share --------------------- --------------------- Sale 2 309.55 USD/ Share --------------------- --------------------- Sale 1 302.81 USD/ Share --------------------- --------------------- (b) Derivatives transactions (other than options transactions) Product name, Nature of transaction Number of securities Price per unit (Note e.g. CFD (Note 6) (Note 7) 5) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, Number of securities Exercise Type, e.g. Expiry Option money e.g. call option selling, to which the price American, date paid/received purchasing, option relates European per unit varying etc. (Note 7) etc. (Note 5) (ii) Exercising Product name, e.g. call Number of securities Exercise price per unit option (Note 5)
(MORE TO FOLLOW) Dow Jones Newswires
November 20, 2015 10:18 ET (15:18 GMT)
1 Year Pfizer Chart |
1 Month Pfizer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions